Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Morgan Sitenga
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5152457804
Toxicity attribution during enfortumab vedotin plus pembrolizumab therapy in urothelial carcinoma: a practical framework
2026
·
Jabra Zarka
, Daniel S Childs
, et al.
·
The Oncologist
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
